GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coherus Oncology Inc (FRA:8C5) » Definitions » Net Policyholder Benefits/Claims

Coherus Oncology (FRA:8C5) Net Policyholder Benefits/Claims


View and export this data going back to 2014. Start your Free Trial

What is Coherus Oncology Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Coherus Oncology Business Description

Industry
Traded in Other Exchanges
Address
333 Twin Dolphin Drive, Suite 600, Redwood City, CA, USA, 94065
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.